Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

467

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2009

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

liraglutide

1.8 mg once daily for s.c. (under the skin) injection.

DRUG

exenatide

10 mcg twice daily for s.c. (under the skin) injection.

Trial Locations (125)

1000

Novo Nordisk Investigational Site, Skopje

1030

Novo Nordisk Investigational Site, Vienna

1130

Novo Nordisk Investigational Site, Vienna

1211

Novo Nordisk Investigational Site, Geneva

1525

Novo Nordisk Investigational Site, Ljubljana

2650

Novo Nordisk Investigational Site, Hvidovre

2820

Novo Nordisk Investigational Site, Gentofte Municipality

3010

Novo Nordisk Investigational Site, Bern

4011

Novo Nordisk Investigational Site, Stavanger

4031

Novo Nordisk Investigational Site, Basel

5000

Novo Nordisk Investigational Site, Odense

5021

Novo Nordisk Investigational Site, Bergen

6900

Novo Nordisk Investigational Site, Lugano

8000

Novo Nordisk Investigational Site, Århus C

Novo Nordisk Investigational Site, Novo Mesto

8036

Novo Nordisk Investigational Site, Graz

9000

Novo Nordisk Investigational Site, Aalborg

11108

Novo Nordisk Investigational Site, Narbonne

11768

Novo Nordisk Investigational Site, Northport

14612

Novo Nordisk Investigational Site, Falkensee

15110

Novo Nordisk Investigational Site, Lahti

15213

Novo Nordisk Investigational Site, Pittsburgh

16602

Novo Nordisk Investigational Site, Altoona

17019

Novo Nordisk Investigational Site, La Rochelle

19152

Novo Nordisk Investigational Site, Philadelphia

22607

Novo Nordisk Investigational Site, Hamburg

23294

Novo Nordisk Investigational Site, Richmond

23606

Novo Nordisk Investigational Site, Newport News

27517

Novo Nordisk Investigational Site, Chapel Hill

29150

Novo Nordisk Investigational Site, Sumter

30076

Novo Nordisk Investigational Site, Roswell

30127

Novo Nordisk Investigational Site, Powder Springs

30318

Novo Nordisk Investigational Site, Atlanta

30625

Novo Nordisk Investigational Site, Hanover

32205

Novo Nordisk Investigational Site, Jacksonville

32216

Novo Nordisk Investigational Site, Jacksonville

32259

Novo Nordisk Investigational Site, Jacksonville

32779

Novo Nordisk Investigational Site, Longwood

33006

Novo Nordisk Investigational Site, Oviedo

33023

Novo Nordisk Investigational Site, Hollywood

33029

Novo Nordisk Investigational Site, Pembroke Pines

33324

Novo Nordisk Investigational Site, Plantation

33907

Novo Nordisk Investigational Site, Fort Myers

34471

Novo Nordisk Investigational Site, Ocala

34769

Novo Nordisk Investigational Site, Saint Cloud

35039

Novo Nordisk Investigational Site, Marburg

35242

Novo Nordisk Investigational Site, Birmingham

35415

Novo Nordisk Investigational Site, Pohlheim

35600

Novo Nordisk Investigational Site, Puerto del Rosario

37404

Novo Nordisk Investigational Site, Chattanooga

44060

Novo Nordisk Investigational Site, Mentor

44718

Novo Nordisk Investigational Site, Canton

44791

Novo Nordisk Investigational Site, Bochum

45206

Novo Nordisk Investigational Site, Cincinnati

45429

Novo Nordisk Investigational Site, Kettering

45439

Novo Nordisk Investigational Site, Dayton

47714

Novo Nordisk Investigational Site, Evansville

53209

Novo Nordisk Investigational Site, Milwaukee

54201

Novo Nordisk Investigational Site, Dommartin-lès-Toul

55108

Novo Nordisk Investigational Site, Saint Paul

55416

Novo Nordisk Investigational Site, Minneapolis

58033

Novo Nordisk Investigational Site, Nevers

60388

Novo Nordisk Investigational Site, Frankfurt

60616

Novo Nordisk Investigational Site, Chicago

61615

Novo Nordisk Investigational Site, Peoria

63303

Novo Nordisk Investigational Site, Dreieich-Sprendlingen

63376

Novo Nordisk Investigational Site, City of Saint Peters

66780

Novo Nordisk Investigational Site, Rehlingen-Siersburg

67059

Novo Nordisk Investigational Site, Ludwigshafen

67346

Novo Nordisk Investigational Site, Speyer

68623

Novo Nordisk Investigational Site, Lampertheim

70121

Novo Nordisk Investigational Site, New Orleans

71083

Novo Nordisk Investigational Site, Herrenberg

72072

Novo Nordisk Investigational Site, Tübingen

73103

Novo Nordisk Investigational Site, Oklahoma City

75230

Novo Nordisk Investigational Site, Dallas

75231

Novo Nordisk Investigational Site, Dallas

75246

Novo Nordisk Investigational Site, Dallas

77030

Novo Nordisk Investigational Site, Houston

78229

Novo Nordisk Investigational Site, San Antonio

78412

Novo Nordisk Investigational Site, Corpus Christi

78731

Novo Nordisk Investigational Site, Austin

79707

Novo Nordisk Investigational Site, Midland

85395

Novo Nordisk Investigational Site, Goodyear

90057

Novo Nordisk Investigational Site, Los Angeles

90701

Novo Nordisk Investigational Site, Artesia

91436

Novo Nordisk Investigational Site, Encino

91978

Novo Nordisk Investigational Site, Spring Valley

92025

Novo Nordisk Investigational Site, Escondido

92869

Novo Nordisk Investigational Site, Orange

94401

Novo Nordisk Investigational Site, San Mateo

94598

Novo Nordisk Investigational Site, Walnut Creek

95816

Novo Nordisk Investigational Site, Sacramento

98502

Novo Nordisk Investigational Site, Olympia

99218

Novo Nordisk Investigational Site, Spokane

320076

Novo Nordisk Investigational Site, Reşiţa

510053

Novo Nordisk Investigational Site, Alba Iulia

720237

Novo Nordisk Investigational Site, Suceava

83404-7596

Novo Nordisk Investigational Site, Idaho Falls

50314-3027

Novo Nordisk Investigational Site, Des Moines

08822

Novo Nordisk Investigational Site, Flemington

08880

Novo Nordisk Investigational Site, South Bound Brook

00029

Novo Nordisk Investigational Site, Helsinki

FI-90100

Novo Nordisk Investigational Site, Oulu

06600

Novo Nordisk Investigational Site, Antibes

DUBLIN 7

Novo Nordisk Investigational Site, Dublin

DUBLIN 8

Novo Nordisk Investigational Site, Dublin

Unknown

Novo Nordisk Investigational Site, Dublin

NO-5012

Novo Nordisk Investigational Site, Bergen

NO-7030

Novo Nordisk Investigational Site, Trondheim

85-822

Novo Nordisk Investigational Site, Bydgoszcz

88-140

Novo Nordisk Investigational Site, Gniewkowo

31-501

Novo Nordisk Investigational Site, Krakow

20-081

Novo Nordisk Investigational Site, Lublin

60-821

Novo Nordisk Investigational Site, Poznan

43-100

Novo Nordisk Investigational Site, Tychy

01-911

Novo Nordisk Investigational Site, Warsaw

50-127

Novo Nordisk Investigational Site, Wroclaw

41-800

Novo Nordisk Investigational Site, Zabrze

00674

Novo Nordisk Investigational Site, Manatí

SI-6000

Novo Nordisk Investigational Site, Koper

08907

Novo Nordisk Investigational Site, L'Hospitalet de Llobregat

07010

Novo Nordisk Investigational Site, Palma de Mallorca

141 86

Novo Nordisk Investigational Site, Stockholm

171 76

Novo Nordisk Investigational Site, Stockholm

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT00518882 - Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes | Biotech Hunter | Biotech Hunter